Argosy Private Equity Invests in Bionix, LLC

Argosy Private Equity Invests in Wittenbach Business Systems

April 22, 2021

Professional Services

Argosy Private Equity has invested in Wittenbach Business Systems, a Sparks, Maryland-based provider of cash management and electronic/physical security solutions for credit unions, financial institutions and retail customers. The investment (Argosy’s second in its sixth lower middle market fund) will support geographic expansion, pursue accretive acquisitions and accelerate growth initiatives.

Argosy Private Equity Acquires Controlling Interest in Barco Products

August 8, 2023

Building Products

Argosy Private Equity acquired a controlling interest in Barco Products, a Batavia, Illinois-based designer, manufacturer and distributor of commercial outdoor site furnishings and traffic safety products. Argosy plans to execute its Value Acceleration Methodology to drive geographic expansion, evaluate add-on acquisitions, and coordinate sales and marketing initiatives to grow the business.

CQ Medical Acquires Bionix Radiation Therapy Business Unit

December 1, 2025

Medical Devices

CQ Medical has acquired the Radiation Therapy business unit from Bionix, expanding CQ Medical’s patient positioning and radiotherapy marking product portfolio. The deal transfers Bionix’s radiation therapy product lines and commercial team to CQ Medical while Bionix retains its Ambulatory Care business based in Maumee, Ohio.

Bain Capital Tech Opportunities Invests R$450M in Bionexo

October 15, 2021

Cloud & SaaS

Bain Capital Tech Opportunities has made a R$450 million growth investment in Bionexo, a São Paulo–headquartered healthcare cloud software and data analytics provider. The funding will be used to expand Bionexo's suite of healthcare SaaS products, accelerate AI/ML development, and pursue transformational M&A to deepen its marketplace and supply‑chain capabilities across Latin America.

Abenex Acquires Cisbio Bioassays from Argos Soditic

June 16, 2016

Biotechnology

French private equity firm Abenex has acquired Cisbio Bioassays from seller Argos Soditic. Abenex will partner with the biotech to support its organic and external growth strategy across pharmaceutical research and in vitro diagnostics; Cisbio has ~210 employees and generates over 85% of revenue outside France.

Bioventus Acquires Bioness, Inc.

March 30, 2021

Medical Devices

Bioventus Inc. acquired Bioness, Inc. for $45 million in up-front consideration plus up to $65 million of contingent consideration, making Bioness a wholly‑owned subsidiary. The acquisition expands Bioventus' rehabilitation and neuromodulation product portfolio and R&D pipeline, and is expected to be accretive to revenue by leveraging Bioventus' global commercial infrastructure.